{
    "2021-12-15": [
        [
            {
                "time": "2023-10-01",
                "original_text": "Veeva's Data Cloud to Aid PharmaEssentia's New Product",
                "features": {
                    "keywords": [
                        "Veeva",
                        "Data Cloud",
                        "PharmaEssentia",
                        "New Product"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "3 Top Medical Instruments Stocks to Counter Industry Headwinds",
                "features": {
                    "keywords": [
                        "Medical Instruments",
                        "Stocks",
                        "Headwinds"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "medical devices",
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Illumina (ILMN) to Develop Synthetic Genomic Data With New Pact",
                "features": {
                    "keywords": [
                        "Illumina",
                        "Synthetic Genomic Data",
                        "New Pact"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "genomics",
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Here's Why You Should Retain Charles River (CRL) Stock for Now",
                "features": {
                    "keywords": [
                        "Charles River",
                        "Retain",
                        "Stock"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "life sciences",
                        "research services"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Should Franklin LibertyQ U.S. Equity ETF (FLQL) Be on Your Investing Radar?",
                "features": {
                    "keywords": [
                        "Franklin LibertyQ",
                        "ETF",
                        "Investing Radar"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "equity ETFs",
                        "financial services"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "VIP Balanced Portfolio Buys Alphabet Inc, Thermo Fisher Scientific Inc, Marsh & McLennan ...",
                "features": {
                    "keywords": [
                        "VIP Balanced Portfolio",
                        "Alphabet",
                        "Thermo Fisher",
                        "Marsh & McLennan"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "technology",
                        "industrial services",
                        "insurance"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}